Updates are available Correction dated 2026-02-05
Click to view Correction: https://doi.org/10.1038/s41467-026-69268-5
-
Authors
Li, Shuo https://orcid.org/0000-0002-1960-6016
Noor, Zorawar S.
Zeng, Weihua
Stackpole, Mary L. https://orcid.org/0000-0003-4432-6718
Ni, Xiaohui https://orcid.org/0000-0002-3626-3588
Zhou, Yonggang
Yuan, Zuyang
Wong, Wing Hung https://orcid.org/0000-0001-7466-2339
Agopian, Vatche G. https://orcid.org/0000-0003-0130-9838
Dubinett, Steven M.
Alber, Frank
Li, Wenyuan https://orcid.org/0000-0002-5029-8525
Garon, Edward B. https://orcid.org/0000-0001-7077-8801
Zhou, Xianghong Jasmine https://orcid.org/0000-0002-4522-7490
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (RO1CA208403)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA0160142)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U01CA230705)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA246329)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U01CA237711)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
California Institute for Regenerative Medicine (CLIN2-10784)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
- License Information
-
More Information
Article History
Received: 16 April 2020
Accepted: 18 June 2021
First Online: 7 July 2021
Change Date: 5 February 2026
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-026-69268-5
Competing interests
: X.J.Z., W.L., and W.H.W. are co-founders of EarlyDiagnostics Inc. X.N., S.L., and M.L.S. are employees of EarlyDiagnostics Inc. X.J.Z and W.H.W serve on the Board of Directors for EarlyDiagnostics. X.J.Z. has an executive leadership position at EarlyDiagnostics. S.M.D. is a scientific advisor to EarlyDiagnostics. X.N., S.L., and M.L.S. are employees of EarlyDiagnostics. S.L., W.Z., M.L.S., X.N., Y.Z., S.M.D. have stock options with EarlyDiagnostics. X.J.Z., W.L., W.H.W., and F.A. are stockholders of EarlyDiagnostics. W.Z., Y.G., and W.L. are consultants for EarlyDiagnostics. X.J.Z., S.L. and W.L. are inventors on a patent application submitted by the Regents of the University of California and licensed to EarlyDiagnostics (Patent No. US20210125683A1). The other authors have no competing interests to declare.
